Recent Quarter Total Invested
$29.85 M
Recent Quarter Institutional Ownership Percentage
42.48%
Total Invested of Last Quarter
$27.60 M
Ownership Percentage of Last Quarter
41.44%
Champions Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | 08/13/2024 | 2.42 M | $12.52 M | 0.00% | 17.81% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2024 | 1.71 M | $8.86 M | 0.00% | 12.61% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 08/12/2024 | 684,628 | $3.54 M | 0.00% | 5.04% |
| VANGUARD GROUP INC | 08/13/2024 | 307,002 | $1.59 M | 258.63% | 2.26% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 122,591 | $633,795 | -1.68% | 0.90% |
| BLACKROCK INC. | 08/13/2024 | 116,072 | $600,093 | 0.34% | 0.85% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 69,304 | $358,302 | 0.00% | 0.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 63,086 | $326,235 | 1.56% | 0.46% |
| MORGAN STANLEY | 08/14/2024 | 43,100 | $222,827 | 5.90% | 0.32% |
| NORTHERN TRUST CORP | 08/14/2024 | 40,463 | $209,193 | -5.21% | 0.30% |
| HIGHTOWER ADVISORS, LLC | 08/13/2024 | 34,308 | $178,000 | 0.00% | 0.25% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 30,697 | $157,000 | 0.00% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 26,749 | $138,293 | 0.00% | 0.20% |
| STATE STREET CORP | 08/14/2024 | 26,553 | $137,279 | 0.00% | 0.20% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 25,273 | $130,661 | -2.14% | 0.19% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 07/26/2024 | 12,252 | $63,000 | 0.00% | 0.09% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 08/09/2024 | 12,000 | $62,040 | -3.07% | 0.09% |
| STIFEL FINANCIAL CORP | 08/13/2024 | 10,942 | $56,573 | -2.23% | 0.08% |
| CITADEL ADVISORS LLC | 08/14/2024 | 10,218 | $52,827 | -20.33% | 0.08% |
| CITADEL ADVISORS LLC | 08/14/2024 | 6,100 | $31,537 | -33.70% | 0.04% |
| CITADEL ADVISORS LLC | 08/14/2024 | 3,300 | $17,061 | 26.92% | 0.02% |
| SIMPLEX TRADING, LLC | 07/25/2024 | 3,004 | $15,000 | 88.10% | 0.02% |
| UBS GROUP AG | 08/14/2024 | 379 | $1,959 | -65.76% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2024 | 133 | $1,000 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 11 | $57 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
Champions Oncology, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CSBR shares?
During the previous two years, 32 institutional investors and hedge funds held shares of Champions Oncology, Inc.. The most heavily invested institutionals were:
Battery Management Corp.: 2.42 M
NEA Management Company, LLC: 1.71 M
TOCQUEVILLE ASSET MANAGEMENT L.P.: 684,628
VANGUARD GROUP INC: 307,002
RENAISSANCE TECHNOLOGIES LLC: 122,591
BlackRock Inc.: 116,072
-
What percentage of Champions Oncology, Inc. stock is owned by institutional investors?
42.48% of Champions Oncology, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CSBR ?
Institutional investors have bought a total of 8.32 M shares in the last 24 months. This purchase volume represents approximately $40.52 M in transactions.